• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人体缺血再灌注中的循环黄嘌呤氧化酶。

Circulating xanthine oxidase in human ischemia reperfusion.

作者信息

Tan S, Gelman S, Wheat J K, Parks D A

机构信息

Department of Pediatrics, University of Alabama at Birmingham 35233, USA.

出版信息

South Med J. 1995 Apr;88(4):479-82. doi: 10.1097/00007611-199504000-00021.

DOI:10.1097/00007611-199504000-00021
PMID:7716606
Abstract

Reactive oxygen species (ROS) generated from xanthine oxidase (XO) play an important role in ischemia-induced injury. We hypothesize that XO and xanthine dehydrogenase (XDH) are released into the circulation with ischemia reperfusion to the human liver and intestine. Blood was drawn from a patient, before and at intervals after an aortic cross-clamp procedure. Plasma was incubated in the presence of xanthine, with NAD+ (for XD +XO) and without NAD+ (for XO). The amount of urate formed was quantified using a high-performance liquid chromatograph (HPLC). The calculated XDH+XO and XO activity increased from 1.88 and 1.66 microU/mg protein, respectively, before the cross clamp to 3.77 and 3.11 microU/mg, respectively, 7 minutes after reperfusion to the superior mesenteric, celiac, and right renal artery beds. The release of a significant biological source of ROS may explain the damage to lung or heart observed after ischemia to the human liver and intestine.

摘要

由黄嘌呤氧化酶(XO)产生的活性氧(ROS)在缺血性损伤中起重要作用。我们推测,在人肝脏和肠道缺血再灌注时,XO和黄嘌呤脱氢酶(XDH)会释放到循环系统中。在主动脉交叉钳夹手术前及术后每隔一段时间从一名患者身上采血。血浆在黄嘌呤存在的情况下,分别添加NAD +(用于检测XD + XO)和不添加NAD +(用于检测XO)进行孵育。使用高效液相色谱仪(HPLC)对生成的尿酸量进行定量。计算得出,在肠系膜上动脉、腹腔动脉和右肾动脉床再灌注7分钟后,XDH + XO和XO活性分别从交叉钳夹前的1.88和1.66微单位/毫克蛋白增加到3.77和3.11微单位/毫克。ROS的一个重要生物来源的释放可能解释了人肝脏和肠道缺血后观察到的肺或心脏损伤。

相似文献

1
Circulating xanthine oxidase in human ischemia reperfusion.人体缺血再灌注中的循环黄嘌呤氧化酶。
South Med J. 1995 Apr;88(4):479-82. doi: 10.1097/00007611-199504000-00021.
2
Histamine: a promoter of xanthine oxidase activity in intestinal ischemia/reperfusion.组胺:肠道缺血/再灌注中黄嘌呤氧化酶活性的促进剂。
J Pediatr Surg. 1990 Feb;25(2):218-22; discussion 222-3. doi: 10.1016/0022-3468(90)90406-y.
3
A reappraisal of xanthine dehydrogenase and oxidase in hypoxic reperfusion injury: the role of NADH as an electron donor.黄嘌呤脱氢酶和氧化酶在缺氧再灌注损伤中的重新评估:NADH作为电子供体的作用。
Free Radic Res. 1998 Feb;28(2):151-64. doi: 10.3109/10715769809065801.
4
Liver ischemia-reperfusion increases pulmonary permeability in rat: role of circulating xanthine oxidase.肝脏缺血再灌注增加大鼠肺通透性:循环黄嘌呤氧化酶的作用
Am J Physiol. 1995 Jun;268(6 Pt 1):G988-96. doi: 10.1152/ajpgi.1995.268.6.G988.
5
Conversion of xanthine dehydrogenase to oxidase in ischemic rat intestine: a reevaluation.缺血大鼠肠道中黄嘌呤脱氢酶向氧化酶的转化:重新评估
Am J Physiol. 1988 May;254(5 Pt 1):G768-74. doi: 10.1152/ajpgi.1988.254.5.G768.
6
Circulating xanthine oxidase: potential mediator of ischemic injury.循环中的黄嘌呤氧化酶:缺血性损伤的潜在介质。
Am J Physiol. 1990 Apr;258(4 Pt 1):G564-70. doi: 10.1152/ajpgi.1990.258.4.G564.
7
Organ distribution and molecular forms of human xanthine dehydrogenase/xanthine oxidase protein.人黄嘌呤脱氢酶/黄嘌呤氧化酶蛋白的器官分布及分子形式
Lab Invest. 1996 Jan;74(1):48-56.
8
[The role of xanthine dehydrogenase (xanthine oxidase) in ischemia-reperfusion injury in rat kidney].[黄嘌呤脱氢酶(黄嘌呤氧化酶)在大鼠肾脏缺血再灌注损伤中的作用]
Nihon Jinzo Gakkai Shi. 1996 Dec;38(12):577-84.
9
Xanthine oxidase released from reperfused hind limbs mediate kupffer cell activation, neutrophil sequestration, and hepatic oxidative stress in rats subjected to tourniquet shock.再灌注后肢释放的黄嘌呤氧化酶介导了止血带休克大鼠的库普弗细胞活化、中性粒细胞隔离和肝脏氧化应激。
Shock. 2000 Nov;14(5):565-71. doi: 10.1097/00024382-200014050-00012.
10
Conversion of xanthine dehydrogenase into xanthine oxidase in rat liver and plasma at the onset of reperfusion after ischemia.缺血后再灌注开始时大鼠肝脏和血浆中黄嘌呤脱氢酶向黄嘌呤氧化酶的转化。
Hepatology. 1994 Jun;19(6):1488-95.

引用本文的文献

1
Liver-Derived, Circulating Xanthine Oxidoreductase Drives Vascular Impairment Associated with Inhalation of Ultrafine Particulates.肝脏来源的循环黄嘌呤氧化还原酶驱动与吸入超细颗粒物相关的血管损伤。
bioRxiv. 2025 May 12:2025.05.07.652261. doi: 10.1101/2025.05.07.652261.
2
Potential Opportunities for Pharmacogenetic-Based Therapeutic Exploitation of Xanthine Dehydrogenase in Cardiovascular Disease.基于药物遗传学对黄嘌呤脱氢酶在心血管疾病中进行治疗性开发的潜在机会。
Antioxidants (Basel). 2024 Nov 22;13(12):1439. doi: 10.3390/antiox13121439.
3
Xanthine oxidoreductase activity in platelet-poor and rich plasma as a oxidative stress indicator in patients required renal replacement therapy.
血小板贫浆和富浆中黄嘌呤氧化还原酶活性作为需要肾脏替代治疗患者的氧化应激标志物。
BMC Nephrol. 2022 Jan 18;23(1):35. doi: 10.1186/s12882-021-02649-8.
4
Shortage of Cellular ATP as a Cause of Diseases and Strategies to Enhance ATP.细胞内三磷酸腺苷(ATP)短缺作为疾病病因及增强ATP的策略
Front Pharmacol. 2019 Feb 19;10:98. doi: 10.3389/fphar.2019.00098. eCollection 2019.
5
Oxidative Stress in Cardiac Tissue of Patients Undergoing Coronary Artery Bypass Graft Surgery: The Effects of Overweight and Obesity.冠状动脉旁路移植术患者心脏组织中的氧化应激:超重和肥胖的影响。
Oxid Med Cell Longev. 2018 Dec 17;2018:6598326. doi: 10.1155/2018/6598326. eCollection 2018.
6
Activity of xanthine oxidase in plasma correlates with indices of insulin resistance and liver dysfunction in patients with type 2 diabetes mellitus and metabolic syndrome: A pilot exploratory study.血浆黄嘌呤氧化酶活性与 2 型糖尿病合并代谢综合征患者胰岛素抵抗和肝功能障碍的相关指标:一项初步探索性研究。
J Diabetes Investig. 2019 Jan;10(1):94-103. doi: 10.1111/jdi.12870. Epub 2018 Jul 7.
7
Ameliorative effect of allopurinol on vascular complications of insulin resistance.别嘌醇对胰岛素抵抗血管并发症的改善作用。
J Diabetes Res. 2015;2015:178540. doi: 10.1155/2015/178540. Epub 2015 Feb 15.
8
Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal.高尿酸血症和黄嘌呤氧化酶其中之一或两者是否对脉管系统直接产生毒性作用?一项批判性评估。
Arthritis Rheum. 2012 Feb;64(2):327-38. doi: 10.1002/art.33369.
9
Oxidative stress and blood-brain barrier dysfunction under particular consideration of matrix metalloproteinases.氧化应激和血脑屏障功能障碍特别考虑基质金属蛋白酶。
Antioxid Redox Signal. 2011 Sep 1;15(5):1305-23. doi: 10.1089/ars.2011.3923. Epub 2011 May 19.
10
Role of urate, xanthine oxidase and the effects of allopurinol in vascular oxidative stress.尿酸、黄嘌呤氧化酶的作用及别嘌呤醇对血管氧化应激的影响
Vasc Health Risk Manag. 2009;5(1):265-72. doi: 10.2147/vhrm.s4265. Epub 2009 Apr 8.